Wellbeing measurement among adults with Charcot-Marie-Tooth disease
- PMID: 39712593
- PMCID: PMC11657789
- DOI: 10.1016/j.hctj.2024.100053
Wellbeing measurement among adults with Charcot-Marie-Tooth disease
Abstract
Background and aims: Wellbeing research among individuals with Charcot-Marie-Tooth disease (CMT) is limited. The goal of the current study is to characterize the challenges experienced by adults with CMT that researchers may miss by utilizing typical strategies to capture mental health and wellbeing.
Methods: In 2021, we recruited 288 US adults with CMT ( = 60 years, 59% Female, 93% White) to take part in an online survey. Participants were presented with validated wellbeing and health measures, in addition to newly created measures specific to CMT, and then asked to provide free-response feedback about aspects of their lived experiences missing from these measures. Thematic analysis were applied to the free-response data to identify CMT-related difficulties that may impact wellbeing among adults with CMT.
Results: Results identified nine CMT-related challenges that are important to individuals with CMT and are often left out of wellbeing assessments in this population. The three most common themes identified were anxiety or worry, coping with loss of function or progression, and difficulty finding knowledgeable medical providers. Further, some aspects of the CMT experience may be comorbid.
Interpretation: These results can be used to inform future research and clinical practice in the CMT population.
Keywords: Disabilities; Inherited peripheral neuropathy; Lived experience; Wellbeing.
© 2024 The Authors.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Genetic epidemiology of Charcot-Marie-Tooth disease.Acta Neurol Scand Suppl. 2012;(193):iv-22. doi: 10.1111/ane.12013. Acta Neurol Scand Suppl. 2012. PMID: 23106488
-
Accelerate Clinical Trials in Charcot-Marie-Tooth Disease (ACT-CMT): A Protocol to Address Clinical Trial Readiness in CMT1A.Front Neurol. 2022 Jun 27;13:930435. doi: 10.3389/fneur.2022.930435. eCollection 2022. Front Neurol. 2022. PMID: 35832173 Free PMC article.
-
Validation of the Italian version of the Charcot-Marie-Tooth Health Index.J Peripher Nerv Syst. 2020 Sep;25(3):292-296. doi: 10.1111/jns.12397. Epub 2020 Jun 24. J Peripher Nerv Syst. 2020. PMID: 32511835 Free PMC article.
-
Charcot-Marie-Tooth disease and related inherited neuropathies.Medicine (Baltimore). 1996 Sep;75(5):233-50. doi: 10.1097/00005792-199609000-00001. Medicine (Baltimore). 1996. PMID: 8862346 Review.
-
The shifting paradigm of Charcot-Marie-Tooth disease.Rev Neurol (Paris). 2015 Jun-Jul;171(6-7):498-504. doi: 10.1016/j.neurol.2014.12.003. Epub 2015 Apr 18. Rev Neurol (Paris). 2015. PMID: 25896909 Review.
References
-
- Smith M., Calder-Dawe O., Carroll P., et al. Mobility barriers and enablers and their implications for the wellbeing of disabled children and young people in Aotearoa New Zealand: a cross-sectional qualitative study. Wellbeing Space Soc. 2021;2 doi: 10.1016/j.wss.2021.100028. - DOI
LinkOut - more resources
Full Text Sources